The 'Birth Day' Prize is an initiative of the European Commission. The Bill & Melinda Gates Foundation (or the Foundation) and Merck Sharp & Dohme Corp., subsidiary of Merck & Co. Inc., Kenilworth, NJ USA (or MSD) have committed to award prizes to winners following evaluation of entries by the Commission.
The objectives of the prize are to:
(a) Reduce maternal and/or new-born deaths, stillbirths and/or maternal and new-born morbidity rates related to giving birth in facility-based deliveries
(b) Improve quality and outcomes of care surrounding facility-based delivery
Expected results
A novel solution to improve the outcome of facility-based deliveries, which might be of a clinical, technological or managerial nature, or a combination of these. The selected solution must take full account of relevant social factors and have the potential of scaling up rapidly.
The European Commission will award a prize of 1 Million EUR.
The Bill & Melinda Gates Foundation and Merck Sharp & Dohme Corp. have each committed to award the winning contestants1 selected by the European Commission.
The additional funding envisaged by the Bill & Melinda Gates Foundation is 1 Million EUR
The additional funding envisaged by Merck Sharp & Dohme Corp. is 500 000 EUR
Up to 2 (two) additional prizes may be awarded.
ELIGIBILITY CRITERIA
The contest is open to all legal entities (i.e. natural or legal persons, including International organisations) or groups of legal entities regardless of place of establishment
The objectives of the prize are to:
(a) Reduce maternal and/or new-born deaths, stillbirths and/or maternal and new-born morbidity rates related to giving birth in facility-based deliveries
(b) Improve quality and outcomes of care surrounding facility-based delivery
Expected results
A novel solution to improve the outcome of facility-based deliveries, which might be of a clinical, technological or managerial nature, or a combination of these. The selected solution must take full account of relevant social factors and have the potential of scaling up rapidly.
The European Commission will award a prize of 1 Million EUR.
The Bill & Melinda Gates Foundation and Merck Sharp & Dohme Corp. have each committed to award the winning contestants1 selected by the European Commission.
The additional funding envisaged by the Bill & Melinda Gates Foundation is 1 Million EUR
The additional funding envisaged by Merck Sharp & Dohme Corp. is 500 000 EUR
Up to 2 (two) additional prizes may be awarded.
ELIGIBILITY CRITERIA
The contest is open to all legal entities (i.e. natural or legal persons, including International organisations) or groups of legal entities regardless of place of establishment
Please note however that special rules apply for Israeli entities3 and for Crimean legal persons and that entities from non-EU Member States that are covered by Council sanctions are not eligible to participate4 (see General Annex C to the Main Work Programme).
Moreover, contestants that have already received an EU or Euratom prize cannot receive a second prize for the same activities.
